17 Jul, 2017
We are pleased to report that CARMA has received approval from the Ethics Committee in Spain. This multi-centre, cross-sectional study of children with perinatally acquired HIV-1 on sustained suppressive antiretroviral therapy started before 2 years of age will begin to enroll in the next few weeks. Submissions in Italy and the UK are ongoing and expected soon.
For more information about the CARMA study and the EPIICAL project, please visit the EPIICAL website.